ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychosomatic Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,564Medicare Part D Prescriptions Filled, Including Refills
$1.28M Total Retail Price of All Prescriptions
614 Patients Receiving at Least One Drug in Part D
16%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
RISPERIDONE 989 48
BENZTROPINE MESYLATE 646 61 R
MIRTAZAPINE 617 90
TRAZODONE HCL 617 47
QUETIAPINE FUMARATE 552 62
BUPROPION HCL SR 545 67
ZOLPIDEM TARTRATE 510 61
CITALOPRAM HBR 509 116
CYMBALTA 473 136
HYDROXYZINE PAMOATE 447 39 R
DIVALPROEX SODIUM ER 431 34
VENLAFAXINE HCL ER 420 68
FLUOXETINE HCL 413 43
LAMOTRIGINE 305 20
LITHIUM CARBONATE 298 12
RISPERDAL CONSTA 296 22
SERTRALINE HCL 288 37
PAROXETINE HCL 272 14
OLANZAPINE 244 37
DIVALPROEX SODIUM 240 17
SEROQUEL 234 42
ABILIFY 218 23
ESCITALOPRAM OXALATE 200 39
AMITRIPTYLINE HCL 190 27 R
ZIPRASIDONE HCL 155 14
BUSPIRONE HCL 144 11
BUPROPION XL 138 13
HALOPERIDOL 135 0
CLOZAPINE 123 33
PROPRANOLOL HCL 120 0
THIOTHIXENE 112 0
METHYLPHENIDATE HCL 103 16
CLOMIPRAMINE HCL 102 0 R
VENLAFAXINE HCL 96 25
LOXAPINE 94 0
DOXEPIN HCL 91 0
HALOPERIDOL DECANOATE 88 0
OXCARBAZEPINE 86 0
AMPHETAMINE SALT COMBO 84 13 S2
FLUPHENAZINE HCL 80 23
LIOTHYRONINE SODIUM 76 0
CLONIDINE HCL 76 15
IMIPRAMINE HCL 73 0 R
PERPHENAZINE 71 0
THIORIDAZINE HCL 70 0 R
SEROQUEL XR 69 15
CARBAMAZEPINE 65 14
LEXAPRO 65 14
PRISTIQ ER 64 14
GEODON 58 0
LUNESTA 56 0
DEXTROAMPHETAMINE-AMPHETAMINE 54 0 S2
STRATTERA 52 0
INVEGA 51 0
NORTRIPTYLINE HCL 50 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.